[1] 汪英颖, 刘尚勤. 多发性骨髓瘤诊治指南解读(2018年)[J]. 临床内科杂志, 2018,35(7):503-504. [2] 鲁阳,刘爱春.多发性骨髓瘤的治疗新进展[J].医学综述,2019,25(17):3417-3421. [3] Dimopoulos MA, Oriol A, Nahi H, et al.Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma[J]. N Engl J Med, 2016, 375(14):1319-1331. [4] King T, Jagger J,Wood J,et al.Best Practice for the Administration of Daratumumab in Multiple Myeloma:Australian Myeloma Nurse Expert Opinion[J]. Asia Pac J Oncol Nurs,2018,5(3):270-284. [5] Solves P, Tur S, Arnao M,et al.Transfusion management in multiple myeloma patients receiving daratumumab: Experience of a single tertiary care centre[J]. Transfus Apher Sci,2020,59(2):102658. |